Tau is a protein expressed in the cells of the human nervous system. These cells, known as neurons, rely on the stability of this protein to ensure communication between the various regions of the brain and spinal cord. Tau proteins bind to microtubules, which are a type of filamentous protein structure that forms the framework of the cell. Tau functions to maintain the shape and the stability of the microtubules, allowing neurotransmitters to be transported in a rapid and efficient manner. Mutations of the Tau protein can lead to neurodegenerative diseases, such as Alzheimer's and frontotemporal dementia, which involve the progressive deterioration of the nervous system. In these conditions, increased amounts of abnormally shaped tau proteins form aggregates in the brain, leading to the breakdown of neuronal connections and impairing communication between brain regions. The tau protein is also involved in the body's defense system. In response to cellular stress, Tau proteins can act as an anti-apoptotic mechanism to protect cells from apoptosis. In addition, tau proteins help to reduce inflammation and promote neuron survival by regulating the release of pro-inflammatory cytokines. Tau proteins have also been suggested to function as regulatory proteins in the brain. Studies have indicated that Tau helps ensure proper functioning of synaptic transmission and neuronal networks, and may play a role in memory formation and recall. Additionally, tau proteins appear to be involved in the maintenance of normal neuronal homeostasis. Overall, the Tau protein performs a wide variety of functions to ensure communication between neurons in the brain and prevent the development of neurodegenerative diseases. Recent advances in research have suggested an increased role of tau proteins in regulation of neuronal functioning and homeostasis. Further research into the regulatory functions of tau proteins will lend more understanding of the normal functioning of neurons and the development of neurological diseases.
Title : Atypical presentation of Juvenile myoclonic epilepsy in a 16-year-old female: A case report
George Diaz, Memorial Healthcare Systems, United States
Title : Triple-network dysfunction, ME/CFS, and the NeuroPhysics Treatment Process “A dynamical systems perspective on psychophysical organization and environmental interaction”
Ken Ware, NeuroPhysics Therapy Institute and Research Centre, Australia
Title : Examining the effects of prenatal neurotoxin exposure on the development of the prefrontal cortex and its impact on executive functioning and attentional capacities in children
David Joseph Sperbeck, Private practice, United States
Title : Neurojourney: A free, digital, and multilingual anticipatory guidance tool for parents and clinicians caring for children with severe neurological impairment
Blyth Lord, Courageous Parents Network, United States
Title : Beyond individual choice: How social influence shapes the neural foundations of economic decision-making
Alvina Ashraf, Eastern Regional High School, United States
Title : Mapping the cytokine landscape in Alzheimer’s disease: A bibliometric analysis of global trends and emerging themes
Anagha Kumble, ThinkNeuro, United States